FEATURED

Managing Malignant Pleural Effusions

Management of malignant pleural effusions should be tailored to the particular patient, depending on preference, prognosis, and variety of underlying disease.

Adjuvant Pertuzumab for HER2+ Breast Cancer

While APHINITY showed a small improvement with adjuvant pertuzumab, it is unclear whether the benefits are worth the cost, time, and toxicity associated with the drug.

GI Cancers Symposium 2018 Coverage

Our complete coverage of the Gastrointestinal Cancers Symposium 2018 meeting in San Francisco, CA.

Fact Sheet: Alcohol Consumption and Cancer

The association of cancer risk and alcohol varies by tumor type, as alcohol consumption has been associated with several different types of cancers.

Looking for a Job?

Access our job board to view over 1,​200 job openings throughout the US.

Treatment Regimens

A full listing of cancer treatment and drug information is available to access.

Latest Features

In the Clinic: Managing Malignant Pleural Effusions

In the Clinic: Managing Malignant Pleural Effusions

Management of malignant pleural effusions should be tailored to the particular patient, depending on preference, prognosis, and variety of underlying disease.

Does Depression Increase the Risk for Mortality Among Patients With Cancer?

Does Depression Increase the Risk for Mortality Among Patients With Cancer?

As failure to recognize depression symptoms contributes to the association between mortality and depression in cancer patients, early recognition and treatment with pharmacologic and/or psychologic support is essential for improving outcomes.

Should Adjuvant Pertuzumab Be Used for Patients With HER2-positive Breast Cancer?

Should Adjuvant Pertuzumab Be Used for Patients With HER2-positive Breast Cancer?

While APHINITY showed a small improvement with adjuvant pertuzumab, it is unclear whether the benefits are worth the cost, time, and toxicity associated with the drug.

Renal Cell Carcinoma: Cost of Treatment May Negate Impact of Treatment Advances

Renal Cell Carcinoma: Cost of Treatment May Negate Impact of Treatment Advances

Access to treatment should be considered as important as the research leading to clinical improvements.

Could Switching to Interferon Avoid an Abnormal Ovarian Response in CML?

Could Switching to Interferon Avoid an Abnormal Ovarian Response in CML?

Among female patients with CML, fertility preservation with ovarian stimulation can be challenging if patients require continuation of TKIs until HSCT.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs